Similar Search Results

The impact of the entry of biosimilars : evidence from Europe

Scott Morton, Fiona; Stern, Ariel D.; Stern, Scott - 2017

Persistent link: https://www.econbiz.de/10011708133

Competition and marketing strategies in the pharmaceutical industry

Slatter, Stuart S.; Slatter, Stuart St. P. - 1977

Persistent link: https://www.econbiz.de/10000001252

Generic competition in the US pharmaceutical industry

Saha, Atanu; Grabowski, Henry G.; Birnbaum, Howard; … - In: International journal of the economics of business 13 (2006) 1, pp. 15-38

Persistent link: https://www.econbiz.de/10003326770

The business of health : the role of competition, markets, and regulation

Ohsfeldt, Robert L.; Schneider, John E. - 2006

? -- Competition in hospital markets : the case of specialty hospitals -- Competition in health insurance markets : the case of managed … care reform -- Competition in pharmaceutical markets : the case of prescription drug marketing -- Conclusions and policy …

Persistent link: https://www.econbiz.de/10003339752

Competition in the pharmaceutical industry : the case of PAH drugs

Green, Kevin C. - In: International journal of the economics of business 16 (2009) 1, pp. 55-71

Persistent link: https://www.econbiz.de/10003825014

Global competition and the United States pharmaceutical industry

Ramrattan, Lall; Szenberg, Michael - In: The American economist : journal of Omnicron Delta … 50 (2006) 2, pp. 65-82

Persistent link: https://www.econbiz.de/10003429430

Brand loyalty, generic entry and price competition in pharmaceuticals in the quarter century after the 1984 Waxman-Hatch legislation

Berndt, Ernst R.; Aitken, Murray L. - 2010

"The NBER Bulletin on Aging and Health provides summaries of publications like this. You can sign up to receive the NBER Bulletin on Aging and Health by email. The landmark Waxman-Hatch Act of 1984 represented a "grand compromise" legislation that sought to balance incentives for innovation by...

Persistent link: https://www.econbiz.de/10008688817

Multimarket competition, mobility barriers, and firm performance

Guedri, Zied; MacGuire, Jean B. - In: Journal of management studies : JMS 48 (2011) 4, pp. 857-890

Persistent link: https://www.econbiz.de/10009158783

Cross-national evidence on generic pharmaceuticals : pharmacy vs. physician-driven markets

Danzon, Patricia Munch; Furukawa, Michael F. - 2011

Persistent link: https://www.econbiz.de/10009240051

Dual signals : how competition makes or breaks interfirm social ties

Trapido, Denis - In: Organization science : a journal of the Institute for … 24 (2013) 2, pp. 498-512

Persistent link: https://www.econbiz.de/10009735519

1
2
3
4
5
6
7
8
9
10
Next
Last